Alamar Biosciences Inc (ALMR) Return on Equity ROE from the second quarter 2026 to second quarter and annually, average high and low, overall ranking from Jun 30 2026 to - CSIMarket
CSIMarket
 


Alamar Biosciences Inc   (ALMR)

Alamar Biosciences Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Alamar Biosciences Inc in the second quarter 2026?
Due to the lack of equity, it was not possible to calculate Alamar Biosciences Inc 's return on equity (ROE) in its second quarter 2026

What is ROE?




Return On Equity (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter

Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -49 -36 -15 -8 0
Return On Equity (TTM) - - - - -
ALMR's Total Ranking # # # # #
Equity (TTM) in Millions 313 -178 -159 0 0
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





ALMR Annual Return On Equity




Total Equity in Millions 0 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions 0 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -





More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ALMR's' Return on Equity at Yahoo Finance
ALMR's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ALMR's Competitors
Subscribers only: Roe for Alamar Biosciences Inc 's Suppliers
Subscribers only: Return On Equity for ALMR's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Glucotrack Inc   1,114.03 %
Elutia Inc   940.81 %
Meiragtx Holdings Plc  283.67 %
Silexion Therapeutics Corp  276.59 %
Actinium Pharmaceuticals Inc  213.46 %
Halozyme Therapeutics Inc   180.63 %
Capforce Inc   168.50 %


Date modified: 2026-09-05T14:53:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.